Search

Author/Creator Pfafferott, Katja

1. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Issue 10249 (15th August 2020)

Authors:
Folegatti, Pedro M; Ewer, Katie J; Aley, Parvinder K; Angus, Brian; Becker, Stephan; Belij-Rammerstorfer, Sandra; Bellamy, Duncan; Bibi, Sagida; Bittaye, Mustapha; Clutterbuck, Elizabeth A; Dold, Christina; Faust, Saul N; Finn, Adam; Flaxman, Amy L; Hallis, Bassam; Heath, Paul; Jenkin, Daniel; La...
Journal:
Lancet
Issue:
Volume 396:Issue 10249(2020)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Issue 1 (19th June 2015)

Authors:
von Delft, Annette; Humphreys, Isla S; Brown, Anthony; Pfafferott, Katja; Lucas, Michaela; Klenerman, Paul; Lauer, Georg M; Cox, Andrea L; Gaudieri, Silvana; Barnes, Eleanor
Journal:
Gut
Issue:
Volume 65:Issue 1(2016)
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search